People who eat a high-fiber diet or increase their fiber intake after a colon cancer diagnosis may be less likely to die of these tumors than individuals who don’t consume much fiber. READ MORE
People who eat a high-fiber diet or increase their fiber intake after a colon cancer diagnosis may be less likely to die of these tumors than individuals who don’t consume much fiber.
A recent study examined the association between colorectal cancer messenger RNA expression of HER3 with response to anti-EGFR agents.
A pooled analysis investigated the prognostic role of DNA mismatch repair status in patients with stage III colon cancer treated with a standard adjuvant chemotherapy regimen.
Recent research has uncovered an association between tumor origin and mortality among patients receiving systemic chemotherapy plus biologic therapy for metastatic colorectal cancer.
Research in Review
A recent study combined and analyzed data from three trials regarding the use of first-line chemotherapy plus selective internal radiotherapy in patients with colorectal cancer and liver metastases.
A majority of older patients with stage II or III rectal adenocarcinoma do not receive standard-of-care treatment.
Patients aged 45 years or younger with colorectal cancer may have better treatment options available to them because of more mutations in their tumors than older patients.
A novel scoring system may identify elderly patients with advanced gastric cancer who may not benefit from chemotherapy.
A pilot program for Direct Access Colonoscopy Screening increased overall screening rates for colorectal cancer by nearly 100%.
Costs associated with maintenance bevacizumab and capecitabine.